Bradykinin Potentiator B, Angiotensin I Converting Enzyme Inhibitor is a proline-rich peptide that modulates enzymatic recognition by stabilizing extended backbone conformations. The sequence enhances bradykinin activity by limiting peptide degradation pathways. Its structural features support studies of enzyme-substrate complementarity. Researchers use it in mapping inhibitory motifs and probing peptide-enzyme interfaces.
CAT No: B09012
2. High fat diet and GLP-1 drugs induce pancreatic injury in mice
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.